Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 1321682
                    [Title] => The age of statins
                    [Summary] => 
It has been 17 years since the first publication of the Scandinavian Simvastatin Survival Study (Lancer ‘1994;344; 1383-9) describing the benefit of coenzyme A reductase inhibitors (statins) on cardiovascular events in patients with coronary heart disease.

                    [DatePublished] => 2014-05-11 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 0
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 195247
                    [Title] => Statins: Bad cholesterol’s nightmare
                    [Summary] => Statins sounded Greek to many a decade ago. Now, it is already a household term to many who associate this type of drugs with effective cholesterol-lowering.


It’s called the nightmare of low-density lipoprotein (LDL), which is the bad cholesterol. Statins significantly reduce LDL. They are the ally of the high-density lipoprotein (HDL), the good cholesterol, which helps clear LDL from the circulation. Statins slightly increase HDL.


                    [DatePublished] => 2003-02-13 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [2] => Array
                (
                    [ArticleID] => 147969
                    [Title] => Cholesterol therapy lowers healthcare costs among diabetic sufferers
                    [Summary] => A recent report shows that diabetic patients taking  cholesterol controlling drug significantly reduced the length and cost of hospitalization due to cardiovascular disease (CVD).  The analysis from the landmark Scandinavian Simvastatin Survival Study (4S) is published in Diabetes Care.



                    [DatePublished] => 2002-01-22 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 1222905
                    [AuthorName] => Chat Alejandro
                    [SectionName] => Health And Family
                    [SectionUrl] => health-and-family
                    [URL] => 
                )

            [3] => Array
                (
                    [ArticleID] => 147159
                    [Title] => Cholesterol therapy lowers healthcare costs among diabetic sufferers
                    [Summary] => A recent report shows that diabetic patients taking  cholesterol controlling drug significantly reduced the length and cost of hospitalization due to cardiovascular disease (CVD).  The analysis from the landmark Scandinavian Simvastatin Survival Study (4S) is published in Diabetes Care.



                    [DatePublished] => 2002-01-15 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 1222905
                    [AuthorName] => Chat Alejandro
                    [SectionName] => Health And Family
                    [SectionUrl] => health-and-family
                    [URL] => 
                )

            [4] => Array
                (
                    [ArticleID] => 146350
                    [Title] => Cholesterol therapy lowers healthcare costs among diabetic sufferers
                    [Summary] => A recent report shows that diabetic patients taking  cholesterol controlling drug significantly reduced the length and cost of hospitalization due to cardiovascular disease (CVD).  The analysis from the landmark Scandinavian Simvastatin Survival Study (4S) is published in Diabetes Care.



                    [DatePublished] => 2002-01-08 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 1222905
                    [AuthorName] => Chat Alejandro
                    [SectionName] => Health And Family
                    [SectionUrl] => health-and-family
                    [URL] => 
                )

            [5] => Array
                (
                    [ArticleID] => 145600
                    [Title] => Cholesterol therapy lowers healthcare costs among diabetic sufferers
                    [Summary] => A recent report shows that diabetic patients taking  cholesterol controlling drug significantly reduced the length and cost of hospitalization due to cardiovascular disease (CVD).  The analysis from the landmark Scandinavian Simvastatin Survival Study (4S) is published in Diabetes Care.



                    [DatePublished] => 2002-01-01 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 1222905
                    [AuthorName] => Chat Alejandro
                    [SectionName] => Health And Family
                    [SectionUrl] => health-and-family
                    [URL] => 
                )

            [6] => Array
                (
                    [ArticleID] => 145283
                    [Title] => Cholesterol therapy lowers healthcare costs among diabetic sufferers
                    [Summary] => A recent report shows that diabetic patients taking  cholesterol controlling drug significantly reduced the length and cost of hospitalization due to cardiovascular disease (CVD).  The analysis from the landmark Scandinavian Simvastatin Survival Study (4S) is published in Diabetes Care.



                    [DatePublished] => 2001-12-29 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 1222905
                    [AuthorName] => Chat Alejandro
                    [SectionName] => Health And Family
                    [SectionUrl] => health-and-family
                    [URL] => 
                )

        )

)

SCANDINAVIAN SIMVASTATIN SURVIVAL STUDY

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 1321682
                    [Title] => The age of statins
                    [Summary] => 
It has been 17 years since the first publication of the Scandinavian Simvastatin Survival Study (Lancer ‘1994;344; 1383-9) describing the benefit of coenzyme A reductase inhibitors (statins) on cardiovascular events in patients with coronary heart disease.

                    [DatePublished] => 2014-05-11 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 0
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 195247
                    [Title] => Statins: Bad cholesterol’s nightmare
                    [Summary] => Statins sounded Greek to many a decade ago. Now, it is already a household term to many who associate this type of drugs with effective cholesterol-lowering.


It’s called the nightmare of low-density lipoprotein (LDL), which is the bad cholesterol. Statins significantly reduce LDL. They are the ally of the high-density lipoprotein (HDL), the good cholesterol, which helps clear LDL from the circulation. Statins slightly increase HDL.


                    [DatePublished] => 2003-02-13 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [2] => Array
                (
                    [ArticleID] => 147969
                    [Title] => Cholesterol therapy lowers healthcare costs among diabetic sufferers
                    [Summary] => A recent report shows that diabetic patients taking  cholesterol controlling drug significantly reduced the length and cost of hospitalization due to cardiovascular disease (CVD).  The analysis from the landmark Scandinavian Simvastatin Survival Study (4S) is published in Diabetes Care.



                    [DatePublished] => 2002-01-22 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 1222905
                    [AuthorName] => Chat Alejandro
                    [SectionName] => Health And Family
                    [SectionUrl] => health-and-family
                    [URL] => 
                )

            [3] => Array
                (
                    [ArticleID] => 147159
                    [Title] => Cholesterol therapy lowers healthcare costs among diabetic sufferers
                    [Summary] => A recent report shows that diabetic patients taking  cholesterol controlling drug significantly reduced the length and cost of hospitalization due to cardiovascular disease (CVD).  The analysis from the landmark Scandinavian Simvastatin Survival Study (4S) is published in Diabetes Care.



                    [DatePublished] => 2002-01-15 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 1222905
                    [AuthorName] => Chat Alejandro
                    [SectionName] => Health And Family
                    [SectionUrl] => health-and-family
                    [URL] => 
                )

            [4] => Array
                (
                    [ArticleID] => 146350
                    [Title] => Cholesterol therapy lowers healthcare costs among diabetic sufferers
                    [Summary] => A recent report shows that diabetic patients taking  cholesterol controlling drug significantly reduced the length and cost of hospitalization due to cardiovascular disease (CVD).  The analysis from the landmark Scandinavian Simvastatin Survival Study (4S) is published in Diabetes Care.



                    [DatePublished] => 2002-01-08 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 1222905
                    [AuthorName] => Chat Alejandro
                    [SectionName] => Health And Family
                    [SectionUrl] => health-and-family
                    [URL] => 
                )

            [5] => Array
                (
                    [ArticleID] => 145600
                    [Title] => Cholesterol therapy lowers healthcare costs among diabetic sufferers
                    [Summary] => A recent report shows that diabetic patients taking  cholesterol controlling drug significantly reduced the length and cost of hospitalization due to cardiovascular disease (CVD).  The analysis from the landmark Scandinavian Simvastatin Survival Study (4S) is published in Diabetes Care.



                    [DatePublished] => 2002-01-01 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 1222905
                    [AuthorName] => Chat Alejandro
                    [SectionName] => Health And Family
                    [SectionUrl] => health-and-family
                    [URL] => 
                )

            [6] => Array
                (
                    [ArticleID] => 145283
                    [Title] => Cholesterol therapy lowers healthcare costs among diabetic sufferers
                    [Summary] => A recent report shows that diabetic patients taking  cholesterol controlling drug significantly reduced the length and cost of hospitalization due to cardiovascular disease (CVD).  The analysis from the landmark Scandinavian Simvastatin Survival Study (4S) is published in Diabetes Care.



                    [DatePublished] => 2001-12-29 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 1222905
                    [AuthorName] => Chat Alejandro
                    [SectionName] => Health And Family
                    [SectionUrl] => health-and-family
                    [URL] => 
                )

        )

)

abtest